. 2024 Sep 19;41(1):41–54. doi: 10.3233/CBM-230303

Table 2.

The univariate analysis between disease free survival (DFS) and clinicopathological characteristics

Variables	Numbers	DFS (months)	5-year survival (%)	$\chi$ 2	$P$ value
Lauren classification				41.731	$<$ 0.001
Diffuse type	302	44.7	49
Intestinal type	436	*	67
mixed type	406	36.933	47
Gender				0.924	0.336
Male	846	*	54
Female	298	*	58
Age				19.242	$<$ 0.001
$<$ 45 years	93	*	58
45–60 years	631	*	60
$\geqslant$ 60 years	420	37.267	47
Tumor site				8.355	0.015
Proximal	466	49.267	49
Middle	376	*	61
Distal	302	*	56
Tumor subtype				84.799	$<$ 0.001
Non-infiltrating type	196	*	83
Borrmann type	863	70.2	51
Infiltrating type	85	18.9	32
Pathological classifications				2.228	0.328
Adenocarcinoma	984	*	55
Mucinous carcinoma	107	68.633	51
Signet ring carcinoma	53	43.733	49
Tumor size				194.55	$<$ 0.001
$\leqslant$ 3 cm	471	*	77
3–6 cm	504	31.433	43
$>$ 6 cm	169	16.967	28
Histopathology classification				53.592	$<$ 0.001
Well differentiated	27	*	96
Moderately differentiated	270	*	70
Poor differentiated	847	46.5	49
Tumor infiltrating depth				258.912	$<$ 0.001
T₁	200	*	97
T₂	155	*	79
T₃	72	*	68
T₄	717	26.167	37
Number of metastatic lymph nodes				404.815	$<$ 0.001
N₀	421	*	87
N₁	206		52
N₂	230	31.533	42
N₃	287	13.233	20
Metastatic lymph nodes ration				458.228	$<$ 0.001
0	421	*	87
$\leqslant$ 0.25	241	*	57
$\leqslant$ 0.5	201	27.9	36
$>$ 0.5	281	12.267	19
AJCC 8^th TNM stage				382.954	$<$ 0.001
I	268	*	96
II	261	*	72
III	615	19.7	31
Vascular nerve infiltrating				144.147	$<$ 0.001
Negative	628	*	70
Positive	516	26.167	36

^*The median survival time was not reached by follow-up, $P<$ 0.05, statistical significance.